Articles

The ALLY Adaptive Cataract Treatment System will be the first EU ALLY commercial installation

A list of 14 risk factors indicate dementia is not an inevitable consequence of aging

The nonprofit Prevent Blindness recognised the awareness month with a slate of resources

In a press release, Roche noted that up to 60% of patients were able to extend treatment intervals to 3 or 4 months

The EMA issued a designation for the small molecule photoswitch, which targets inherited retinal diseases including retinitis pigmentosa

Femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) received approval for patients in Europe with primary open-angle glaucoma

The positive opinion comes with the recommendation that ciclosporin 0.1% be granted marketing authorisation in the European Union

Companies in the retina space announced presentations ahead of the American Society of Retina Specialists meeting, to be held 17-20 July

Investigators conducted a case-control study to investigate the corneal topography parameters and biomechanics in patients with alopecia areata

The organisation has secured £72.75 million for its new eye health centre

A novel formulation may prevent blood vessel growth and vascular leakage in the retina

GLP-1 receptor agonists, such as Wegovy, Ozempic and Novo Nordisk, are becoming more prolific

The company has secured $170 million (approximately €157 million) in Series B funding

Extended daylight hours and plentiful outdoor space make Stockholm a memorable destination for meeting attendees

Patients with corneal astigmatism underwent phacoemulsification and rotationally asymmetric multifocal IOL implantation

Educational resources include handouts, videos and a dedicated webpage on the proper way to use eye drops

Following the MAA in Europe, Altos Biologics plans to pursue approval in target markets including Korea

Faricimab is already approved in the EU and UK for neovascular age-related macular degeneration and diabetic macular oedema

The drug is a biosimilar for aflibercept 2 mg (Eylea)

Apellis will seek re-examination from the CHMP following the opinion

Management of neovascular glaucoma focuses on decreasing retinal ischemia through panretinal photocoagulation and the injection of anti-VEGF agents

A preview of presentations from 4D Molecular Therapeutics and Adverum Biotechnologies

The YOSEMITE/RHINE studies measured changes in the BCVA and CST from baseline to years 1 and 2

The prize, presented by EURETINA and supported by Oculis, will recognise outstanding contributions to retina research

The adaptor was tested by low-vision patients and participants with simulated visual impairment

The diagnostic and monitoring tools use artificial intelligence-based models

Ophthalmologists graded AI bots' answers to questions from patients following cataract surgery

The US Food and Drug Administration issued designations for the allogeneic cell therapy candidate, a therapeutic for corneal oedema

Sustainability, artificial intelligence and economic considerations are hot topics at this year’s meeting